Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FAM

16. Specific lobbying issues

H.R. 1 One Big Beautiful Bill Act; H.R.2557 IVF For Military Families Act; S.2035 Protect IVF Act; H.R.6797 To amend title 10, United States Code, to provide fertility treatment under the TRICARE; Shield laws, chemical abortion drugs, H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 5485 Second Chance at Life Act of 2025; H.R. 6501, Fitzpatrick Discharge Petition #12 Bipartisan Health Insurance Affordability Act; H.R. 6575, Gottheimer Petition #13 Common Ground for Affordable Health Care Act; H.R. 1834, Jeffries Discharge Petition #10 Breaking the Gridlock Act; S.2955 , H.R.6466
Forced Abortion Prevention and Accountability Act; Patient Protection and Affordable Care Act; Abortion funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act; S.3385
Lower Health Care Costs Act; H.R.5371 Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act; Contraception issues; IVF issues; National Defense Authorization Act; Supreme Court Decisions; S. 1631, H. R. 5646
Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes;
H.R. 795 Pregnancy Is Not an Illness Act; H.R. 796 Second Chance for Moms Act; H.R. 1349
Womens Protection in Telehealth Act; H.R. 1525 Protecting Life from Chemical Abortions Act; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; H.R. 729 Teleabortion Prevention Act of 2025; S.3389 Lowering Health Care Costs for Americans Act; Presidential Administration Actions; S.3011 Prohibiting Abortion & Transgender Procedures on the Exchanges Act; S.3264, H.R.6538 More Affordable Care Act; H.R. 6703
Lower Health Care Premiums for All Americans Act; S.3391 Accountability for Better Care Act of 2025; S. 3386 Health Care Freedom for Patients Act of 2025; H.R.6512 To Empower American Families with Direct Control Over Healthcare Dollars, Codify President Trump's Proven Reforms for Flexibility and Choice, Prohibit Taxpayer Funding for Abortion and Gender Transition Procedures, Eliminate Waste and Fraud in the Affordable Care Act, and Reject Extensions of Enhanced Subsidies to Insurance Companies; H.R.1157 Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act; H.R.2589 Consensual Donation and Research Integrity Act of 2025; H.R.5969
LABEL Act; H.Res.803 Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes; H.R. 6372 D.C. Shield Law Repeal Act; H.R.6359 Pregnant Students Rights Act; H.R. 6191
No Taxpayer Funded Abortion Travel for Illegal Aliens Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 1 One Big Beautiful Bill Act; Shield Laws; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 5485
Second Chance at Life Act of 2025; H.R. 6501, Fitzpatrick Discharge Petition #12
Bipartisan Health Insurance Affordability Act; H.R. 6575, Gottheimer Petition #13
Common Ground for Affordable Health Care Act; H.R. 1834, Jeffries Discharge Petition #10
Breaking the Gridlock Act; Patient Protection and Affordable Care Act; Contraception Issues; National Defense Authorization Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 795 Pregnancy Is Not an Illness Act; H.R. 796 Second Chance for Moms Act; H.R. 1349
Womens Protection in Telehealth Act; H.R. 1525 Protecting Life from Chemical Abortions Act; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; H.R. 729 Teleabortion Prevention Act of 2025; S.3389 Lowering Health Care Costs for Americans Act; Presidential Administration Actions; S.3011 Prohibiting Abortion & Transgender Procedures on the Exchanges Act; S.3264, H.R.6538 More Affordable Care Act; H.R. 6703
Lower Health Care Premiums for All Americans Act; S.3391 Accountability for Better Care Act of 2025; S. 3386 Health Care Freedom for Patients Act of 2025; H.R.6512 To Empower American Families with Direct Control Over Healthcare Dollars, Codify President Trump's Proven Reforms for Flexibility and Choice, Prohibit Taxpayer Funding for Abortion and Gender Transition Procedures, Eliminate Waste and Fraud in the Affordable Care Act, and Reject Extensions of Enhanced Subsidies to Insurance Companies; H.R.1157 Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

H.R. 1 One Big Beautiful Bill Act; Dismemberment Abortion Ban Act; IVF issues; Presidential Administration Actions; H.R.2589 Consensual Donation and Research Integrity Act of 2025

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code INS

16. Specific lobbying issues

H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; H.R. 6501, Fitzpatrick Discharge Petition #12 Bipartisan Health Insurance Affordability Act; H.R. 6575, Gottheimer Petition #13 Common Ground for Affordable Health Care Act; H.R. 1834, Jeffries Discharge Petition #10 Breaking the Gridlock Act; Patient Protection and Affordable Care Act; Abortion funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S.3385 Lower Health Care Costs Act; H.R.5371 Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; Contraception Issues; IVF Issues; S.3389 Lowering Health Care Costs for Americans Act; S.3011 Prohibiting Abortion & Transgender Procedures on the Exchanges Act; S.3264, H.R.6538 More Affordable Care Act; H.R. 6703 Lower Health Care Premiums for All Americans Act; S.3391
Accountability for Better Care Act of 2025; S. 3386 Health Care Freedom for Patients Act of 2025; H.R.6512 To Empower American Families with Direct Control Over Healthcare Dollars, Codify President Trump's Proven Reforms for Flexibility and Choice, Prohibit Taxpayer Funding for Abortion and Gender Transition Procedures, Eliminate Waste and Fraud in the Affordable Care Act, and Reject Extensions of Enhanced Subsidies to Insurance Companies; H.R.1157 Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; H.R. 6501, Fitzpatrick Discharge Petition #12 Bipartisan Health Insurance Affordability Act; H.R. 6575, Gottheimer Petition #13 Common Ground for Affordable Health Care Act; H.R. 1834, Jeffries Discharge Petition #10 Breaking the Gridlock Act; Patient Protection and Affordable Care Act; Contraception Issues; Supreme Court Decisions; S.3389 Lowering Health Care Costs for Americans Act; Presidential Administration Actions; S.3011 Prohibiting Abortion & Transgender Procedures on the Exchanges Act; S.3264, H.R.6538 More Affordable Care Act; H.R. 6703 Lower Health Care Premiums for All Americans Act; S.3391 Accountability for Better Care Act of 2025; H.R.6512 To Empower American Families with Direct Control Over Healthcare Dollars, Codify President Trump's Proven Reforms for Flexibility and Choice, Prohibit Taxpayer Funding for Abortion and Gender Transition Procedures, Eliminate Waste and Fraud in the Affordable Care Act, and Reject Extensions of Enhanced Subsidies to Insurance Companies; H.R.1157 Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Shield Laws; Chemical abortion drugs; H.R. 5485 Second Chance at Life Act of 2025; Supreme Court Decisions; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629
Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 795 Pregnancy Is Not an Illness Act; H.R. 796
Second Chance for Moms Act; H.R. 1349 Womens Protection in Telehealth Act; H.R. 1525
Protecting Life from Chemical Abortions Act; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; H.R. 729
Teleabortion Prevention Act of 2025; Presidential Administration Actions; H.R.5969
LABEL Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FOR

16. Specific lobbying issues

Presidential Administration Actions

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

H.R. 1 One Big Beautiful Bill Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Patient Protection and Affordable Care Act; Abortion Funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S. 5371 Continuing Appropriations and Extensions Act, 2026; Administration Personnel and Judicial Nominees; S.3385 Lower Health Care Costs Act; S.3264, H.R.6538 More Affordable Care Act; H.R. 6703 Lower Health Care Premiums for All Americans Act; S.3391 Accountability for Better Care Act of 2025; S. 3386 Health Care Freedom for Patients Act of 2025; H.R.6512 To Empower American Families with Direct Control Over Healthcare Dollars, Codify President Trump's Proven Reforms for Flexibility and Choice, Prohibit Taxpayer Funding for Abortion and Gender Transition Procedures, Eliminate Waste and Fraud in the Affordable Care Act, and Reject Extensions of Enhanced Subsidies to Insurance Companies; H.R.1157 Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CIV

16. Specific lobbying issues

Supreme Court Decisions; H.R.6359 Pregnant Students Rights Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CON

16. Specific lobbying issues

Supreme Court Decisions

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Presidential Administration Actions

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code DEF

16. Specific lobbying issues

Presidential Administration Actions; H.R.2557 IVF For Military Families Act; National Defense Authorization Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code GOV

16. Specific lobbying issues

Presidential Administration Actions

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code DOC

16. Specific lobbying issues

Presidential Administration Actions; H.R. 6372 D.C. Shield Law Repeal Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LAW

16. Specific lobbying issues

S.2955 , H.R.6466 Forced Abortion Prevention and Accountability Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 1349 Womens Protection in Telehealth Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; Presidential Administration Actions; H.R. 6372
D.C. Shield Law Repeal Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

H.R.6359 Pregnant Students Rights Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 6191 No Taxpayer Funded Abortion Travel for Illegal Aliens Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes